Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
4,803 total articles
SiTime's acquisition of Renesas' timing business materially changes the risk/reward. The deal would nearly double revenue if the $300M run-rate holds, but it's financed with cash, equity and $900M of committed debt. Given a stretched valuation (price-to-sales ~31.8) and limited free cash flow, this makes buying here less attractive. We prefer a tac…
Disney shares trade near $99.80 after a period of volatility tied to CEO transition uncertainty. With Josh D'Amaro elevated to CEO from the Experiences unit and streaming profitability turning positive, the company has both a clearer leadership path and improving cash generation. At roughly 15x earnings and with $7.06B in free cash flow, Disney off…
NewLake Capital Partners (NLCP) offers a compelling income-focused play in cannabis via a high yield that is backed by $106.3M of liquidity and positive AFFO. Against MSOS — a broad cannabis equity ETF — NLCP is a trade for investors who want cash flow and downside cushioning rather than pure upside from an industry rebound. This piece lays out a m…
Obsidian Energy (OBE) is an under-followed Canadian E&P trading at a modest market cap of ~$595M with tangible optionality after the $301M Cardium divestiture. The balance sheet improvement and resumed production at Harmon Valley create a textbook swing-trade setup: entry at $8.83, stop at $7.50, target $12.00 over a mid-term (45 trading days) hori…
Celestica is uniquely positioned to capture a disproportionate share of AI server and networking assembly demand. With a strategic AMD partnership, strong free cash flow, and healthy profitability metrics, the stock is an actionable long for investors who want exposure to the AI datacenter buildout without buying hyperscalers or chipmakers directly…
Golar LNG (GLNG) offers a compelling mid-term long: secured long-dated charters create multi-billion dollar EBITDA backlog while structural tightness in global LNG markets supports higher utilization and spot premiums. Entry at current levels provides asymmetric upside to a $66 target with a defined $45 stop, while convertible issuance and project …
Shares of The Trade Desk (TTD) have been demolished by headline risk and macro pressure, yet the core business still generates strong margins, cash flow, and double-digit growth. With a market cap under $10B, free cash flow nearing $800M, and a conservatively priced multiple, this is a tactical long with defined risk controls and room for meaningfu…
Playtika trades at $3.19 with a $1.21B market cap and roughly $2.92B enterprise value after a deal that left the company levered. With free cash flow of $531.4M and price-to-free-cash-flow near 2.3, the stock looks cheap on cash generation but vulnerable to dividend cuts, refinancing risk, or operational drawdowns. This trade targets a rerating dri…
Celestica ($CLS) just handed us a tradable setup: constructive technical momentum, a clear strategic win with AMD on rack-scale AI platforms, and free cash flow to support execution. Valuation is elevated but justified by 37% ROE and accelerating revenue mix toward high-margin AI server builds. This trade plan lays out an entry at $328.54, a stop a…
Abercrombie & Fitch is executing large buybacks funded by robust free cash flow and healthy margins. Valuation metrics - P/E near 9-10 and EV/EBITDA ~4.5 - leave room for upside, but mixed guidance and mid-cycle retail headwinds keep the recovery uneven. Trade plan: enter long at $103.49, target $125, stop $95, position horizon ~180 trading days.
Southwest Airlines (LUV) faces near-term earnings pressure from a sudden jump in jet fuel prices, but the stock now offers a tactical long opportunity for disciplined traders. We lay out an actionable entry at $37.50, a stop at $30.00 and a target of $52.00 tied to normalization of fuel costs and seasonal revenue reacceleration. Expect volatility; …
Block is a buy here based on accelerating banking activity inside Cash App, improving payments margins at Square, and clear paths to operational leverage. Detailed financials were not available at the time of writing, so this thesis leans on observable business trends and a clear risk-managed entry, stop, and target plan.
Sea (SE) is trading near $85 after a painful derating from last year’s highs despite record 2025 revenue of $22.9B and a stronger balance sheet. Weak sentiment and margin anxiety created an entry window. This trade targets recovery as Shopee and SeaMoney reinvest for durable share gains while Garena stabilizes.
Nurix Therapeutics is trading at $16.24 after a constructive corporate update and strong Phase 1 data for its BTK degrader bexobrutideg. With DAYBreak pivotal enrollment underway, a planned Phase 3 start by mid-2026, and a healthy cash position of $540.7M, we rate NRIX a Strong Buy. Our trade plan targets $24.00 over a 180 trading day horizon with …
JPMorgan ($JPM) is trading near $310 after a run-up into earnings week. The bank's $2B-per-year AI savings narrative, industry-leading trading franchise and conservative balance sheet set up a favorable risk/reward into the April results. We recommend a tactical long with an entry at $310.00, a stop at $295.00 and a target of $335.00 over a mid-ter…
The Trade Desk (TTD) has collapsed from its highs and now trades at a valuation more typical of a mature software business despite continued revenue growth, high gross margins, and meaningful free cash flow. Management insider buying, oversold technicals, and an attainable path to margin recovery make TTD a high-conviction, deep-value long for pati…
Nano Labs is trading at a fraction of prior highs with a market cap under $71M, a P/E of 3.7 and PB of 0.63. Management has cut costs aggressively and built a sizable BNB reserve; CEO buying and improving technicals add to the bull case. This trade targets a recovery re-rating over the next 180 trading days while keeping a tight damage-limiting sto…
<p>Meta's Muse Spark launch on 04/08/2026 is more than PR — it is the first clear sign that the company's AI investment is transitioning from R&D to product leverage across its Family of Apps. The stock has already reacted, and the setup now offers an actionable long with defined entry, stop, and target levels tied to fundamentals and technical pos…
British American Tobacco offers a 5.1% yield, a modest valuation (PE ~13) and exposure to high-growth oral nicotine pouches and cannabis investments. That mix creates a trade setup with defined upside to the 52-week high and downside protection via a stop below recent support. This idea is a swing trade that pairs income with a catalyst-driven re-r…
Revolve is executing on a Growth-At-a-Reasonable-Price thesis: mid-single-digit top-line growth, expanding profitability, positive free cash flow and no long-term debt. At $25.74 the stock trades at ~29x earnings and 1.45x sales with a $1.84B market cap, leaving room for upside if active customers and owned-brand penetration continue to improve.
Intel's recent string of strategic wins - including a prominent role in the Terafab project - and accelerating momentum in Intel Foundry Services make a high-conviction, actionable long trade. Market validation from partners and improving technicals support a longer-term play while execution and capital intensity remain real risks. Entry $60.50, ta…
Genmab is a high-quality antibody therapeutics developer trading at $28.54 with an $18.1B market cap. Recent Phase 3 results for epcoritamab (PFS positive, OS non-significant), the acquisition of Merus' petosemtamab and a 4.99% stake from Orbis make the stock sensitive to a cluster of near-term binaries. I outline a mid-term (45 trading days) long …
Nasdaq's core marketplace and expanding fintech footprint are showing tangible organic momentum even as macro uncertainty pressures near-term volumes. The stock is trading below key moving averages, offers a 1.2% yield, generates roughly $2.0B in free cash flow and has a valuation that still leaves upside if pilots and product rollouts accelerate. …
Elemental Royalty (ELE) is a focused precious-metals royalty acquirer trading at a $1.26B market cap. The company owns uncapped royalties across producing and near-producing mines and recently monetized a Nordic unit while retaining a 1% NSR in the region. With gold price direction, an acquisitive mandate, and a lean team, ELE offers a tradeable lo…
<p>Amadeus' U.S. OTC listing has been under pressure recently, but the technical picture and a rising short burden suggest the down leg may be stabilizing. With MACD turning positive, price sitting just below key short-term averages and short interest elevated, there is a tradeable asymmetric setup: limited downside with a clear recovery path to pr…
